US Patent Issued to Hudson Institute of Medical Research on Aug. 12 for "CXCL10 binding proteins and uses thereof" (Australian Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,384,838, issued on Aug. 12, was assigned to Hudson Institute of Medical Research (Australia).

"CXCL10 binding proteins and uses thereof" was invented by Andrew N. Stephens (Knoxfield, Australia), Adam Rainczuk (Belgrave, Australia) and Sung-Woog Kang (Malvern East, Australia).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to C-X-C motif chemokine ligand 10 (CXCL10) binding proteins and uses thereof. The present invention also relates to methods of detecting and/or diagnosing a condition in a subject, comprising determining a level of CXCL10 in the subject."

The patent was filed on June 26, 2023, under Application No. 18/341...